Arbitration panel rules in favor of Lilly in complaint filed by Adocia
A Chicago-based arbitration panel ruled in favor of Eli Lilly and Company in a claim filed by Adocia S.A. over the companies’ prior collaboration on a rapid-acting insulin.
Featured Posts
Top 10 Pipelines To Watch: 2019 Annual Report
The return on R&D investment for leading biopharmaceutical manufacturers fell to a nine-year low while the U.S. FDA approved a record-breaking amount of novel medicines during 2018.
Pharma Innovators Special Feature 2018: Focus on innovation
In seeking innovative players that could change pharma and healthcare, Med Ad News found the developer of an app that helps people determine what illnesses are in their neighborhoods; the creator of a wearable injector that allows patients on biologics to receive these drugs outside the clinic; and a designer of a deep learning network aimed at giving pharma and healthcare companies a handle on their data.
First Year After Launch Special Feature 2018: Don’t look back, someone might be gaining
The top performers of the launch class of 2016 have very little in common – aside from the fact that none of them came from a “classic” big pharma house.
Edwards Lifesciences recalls delivery system for Sapien heart valves
Medical device maker Edwards Lifesciences Corp. is recalling the company’s Sapien 3 Ultra delivery system after burst balloons during implantation led to several injuries and a death, said the U.S. Food and Drug Administration on Thursday.
First Commercial Platform with Mutations and CNV Insights from the Same Cell on Single Platform
San Francisco-based Mission Bio Inc. launched an addition to the company’s Tapestri Platform that provides it the ability to track the full scope genomics of cancer in terms of single-cell capabilities.
Novo Nordisk and Mylan Battle Over Generic Versions of Victoza
Denmark’s Novo Nordisk filed a lawsuit in a Delaware district court against generic drugmaker Mylan.
NuCana’s Pancreatic Cancer Trial Halted Due to Futility
Shares of U.K.-based NuCana were down more than 21 percent after the company announced suspended enrollment of patients in a late-stage pancreatic cancer study.
Pfizer invests $500 million in expanding gene therapy facility
Pfizer Inc. is investing $500 million to expand a manufacturing facility in Sanford, North Carolina, that plays a central role in the company’s efforts to become a major player in gene therapy.
Fitbit eyes one million new users in Singapore health scheme
Fitbit Inc. won a contract with the Singapore government to provide fitness trackers and services to up to one million of the country’s citizens as part of a health initiative that begins in October 2019.
New Campaign Focuses on Fighting Superbugs
Leading scientists, public policy experts and biotech industry leaders joined forces to launch “Working to Fight AMR,” a coalition working to raise public awareness of the growing threat posed by antimicrobial resistance.
Sarepta shares sink 14% after shock FDA rejection
Shares of Sarepta Therapeutics Inc. plunged 14 percent after the U.S. health regulator, in an unexpected move, declined to approve the drugmaker’s newest treatment for a muscle-wasting disorder.
Elanco to become No. 2 in animal health with $7.6 billion Bayer deal
Elanco Animal Health agreed to buy Bayer’s veterinary drugs unit in a cash and stock deal valued at $7.6 billion, creating the second-largest maker of medicines for pets and livestock and expanding Elanco’s reach online.
Ad Right Top
MedAdNews
Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com. 
August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!